Cargando…

The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study

BACKGROUND: Most people with sore throat do not benefit from antibiotic treatment, but nearly three-quarters of those presenting in primary care are prescribed antibiotics. A test that is predictive of bacterial infection could help guide antibiotic prescribing. Calprotectin is a biomarker of neutro...

Descripción completa

Detalles Bibliográficos
Autores principales: Schofield, Behnaz, Gregory, Clive, Gal, Micaela, Gillespie, David, Naik, Gurudutt, Hay, Alastair, Francis, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330218/
https://www.ncbi.nlm.nih.gov/pubmed/31964636
http://dx.doi.org/10.3399/bjgpopen20X101006
_version_ 1783553068622675968
author Schofield, Behnaz
Gregory, Clive
Gal, Micaela
Gillespie, David
Naik, Gurudutt
Hay, Alastair
Francis, Nick
author_facet Schofield, Behnaz
Gregory, Clive
Gal, Micaela
Gillespie, David
Naik, Gurudutt
Hay, Alastair
Francis, Nick
author_sort Schofield, Behnaz
collection PubMed
description BACKGROUND: Most people with sore throat do not benefit from antibiotic treatment, but nearly three-quarters of those presenting in primary care are prescribed antibiotics. A test that is predictive of bacterial infection could help guide antibiotic prescribing. Calprotectin is a biomarker of neutrophilic inflammation, and may be a useful marker of bacterial throat infections. AIM: To assess the feasibility of measuring calprotectin from throat swabs, and assess whether individuals with sore throats likely to be caused by streptococcal infections have apparently higher throat calprotectin levels than other individuals with sore throat and healthy volunteers. DESIGN & SETTING: A proof of concept case–control study was undertaken, which compared primary care patients with sore throats and healthy volunteers. METHOD: Baseline characteristics and throat swabs were collected from 30 primary care patients with suspected streptococcal sore throat, and throat swabs were taken from 10 volunteers without sore throat. Calprotectin level determination and rapid antigen streptococcal testing were conducted on the throat swab eluents. Calprotectin levels in the following groups were compared: volunteers without a sore throat; all patients with a sore throat; patients with a sore throat testing either negative or positive for streptococcal antigen; and those with lower and higher scores on clinical prediction rules for streptococcal sore throat. RESULTS: Calprotectin was detected in all throat swab samples. Mean calprotectin levels were numerically higher in patients with sore throat compared with healthy volunteers, and sore throat patients who had group A streptococci antigen detected compared with those who did not. CONCLUSION: Calprotectin can be measured from throat swab samples and levels are consistent with the hypothesis that streptococcal infection leads to higher throat calprotectin levels. This hypothesis will be tested in a larger study.
format Online
Article
Text
id pubmed-7330218
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Royal College of General Practitioners
record_format MEDLINE/PubMed
spelling pubmed-73302182020-07-07 The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study Schofield, Behnaz Gregory, Clive Gal, Micaela Gillespie, David Naik, Gurudutt Hay, Alastair Francis, Nick BJGP Open Research BACKGROUND: Most people with sore throat do not benefit from antibiotic treatment, but nearly three-quarters of those presenting in primary care are prescribed antibiotics. A test that is predictive of bacterial infection could help guide antibiotic prescribing. Calprotectin is a biomarker of neutrophilic inflammation, and may be a useful marker of bacterial throat infections. AIM: To assess the feasibility of measuring calprotectin from throat swabs, and assess whether individuals with sore throats likely to be caused by streptococcal infections have apparently higher throat calprotectin levels than other individuals with sore throat and healthy volunteers. DESIGN & SETTING: A proof of concept case–control study was undertaken, which compared primary care patients with sore throats and healthy volunteers. METHOD: Baseline characteristics and throat swabs were collected from 30 primary care patients with suspected streptococcal sore throat, and throat swabs were taken from 10 volunteers without sore throat. Calprotectin level determination and rapid antigen streptococcal testing were conducted on the throat swab eluents. Calprotectin levels in the following groups were compared: volunteers without a sore throat; all patients with a sore throat; patients with a sore throat testing either negative or positive for streptococcal antigen; and those with lower and higher scores on clinical prediction rules for streptococcal sore throat. RESULTS: Calprotectin was detected in all throat swab samples. Mean calprotectin levels were numerically higher in patients with sore throat compared with healthy volunteers, and sore throat patients who had group A streptococci antigen detected compared with those who did not. CONCLUSION: Calprotectin can be measured from throat swab samples and levels are consistent with the hypothesis that streptococcal infection leads to higher throat calprotectin levels. This hypothesis will be tested in a larger study. Royal College of General Practitioners 2020-01-22 /pmc/articles/PMC7330218/ /pubmed/31964636 http://dx.doi.org/10.3399/bjgpopen20X101006 Text en Copyright © 2020, The Authors https://creativecommons.org/licenses/by/4.0/ This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/ )
spellingShingle Research
Schofield, Behnaz
Gregory, Clive
Gal, Micaela
Gillespie, David
Naik, Gurudutt
Hay, Alastair
Francis, Nick
The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
title The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
title_full The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
title_fullStr The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
title_full_unstemmed The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
title_short The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
title_sort feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group a streptococcus: a case–control feasibility study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330218/
https://www.ncbi.nlm.nih.gov/pubmed/31964636
http://dx.doi.org/10.3399/bjgpopen20X101006
work_keys_str_mv AT schofieldbehnaz thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT gregoryclive thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT galmicaela thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT gillespiedavid thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT naikgurudutt thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT hayalastair thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT francisnick thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT schofieldbehnaz feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT gregoryclive feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT galmicaela feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT gillespiedavid feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT naikgurudutt feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT hayalastair feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy
AT francisnick feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy